Label Image (Lbl530024643)
Losartan Potassium
Product Images NDC 53002-4643
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-4643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Losartanaddress2 (Losartanaddress2)
Losartanfigure1 (Losartanfigure1)
Losartanfigure2 (Losartanfigure2)
This text seems to be a part of a graph showing the Adjusted Risk Reduction in percentage (26%) with a p-value of 0.001. The x-axis of the graph shows the study months ranging from 6 months to 66 months. However, there is incomplete information and no context as to what "fstslinor-fatal svoce" refers to.*
Losartanfigure3 (Losartanfigure3)
Losartanfigure4 (Losartanfigure4)
The text seems to contain numerical data only, without any specific context or additional information to provide a description. It appears to be displaying the percentage of patents with some event related to risk reduction (18.1%), but without any further details on what this event entails. The string "0022" and "Months" might refer to different variables or labels used in the data analysis. Therefore, a meaningful description cannot be generated from this text alone.*
Losartanstructure (Losartanstructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
